Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Resmed Inc Announces Changes In Board Of Directors


Wednesday, 20 Feb 2013 04:59pm EST 

Resmed Inc announced that effective March 1, 2013, Michael (Mick) Farrell will succeed Dr. Peter C. Farrell as ResMed's chief executive officer (CEO) and be appointed to its board of directors. Robert (Rob) Douglas will become ResMed's president and chief operating officer (COO). Current CEO, chairman of the board and founder, Dr. Farrell, will become executive chairman. 

Company Quote

57.36
-0.03 -0.05%
26 Dec 2014